| Literature DB >> 33815033 |
Gamze Keskin1, Sibel Tunç Karaman1, Okcan Basat1.
Abstract
INTRODUCTION: Smoking increases the risk of arrhythmia. QT dispersion (QTd) is an important indicator for the determination of ventricular arrhythmia. In this study, we aimed to determine the arrhythmia risk by evaluating QTd in smokers and to assess the relationship between the level of nicotine addiction and carbon monoxide (CO) level in the expiratory air.Entities:
Keywords: QT dispersion; arrhythmia; exhaled carbon monoxide; smoking
Year: 2021 PMID: 33815033 PMCID: PMC8010797 DOI: 10.18332/tid/133053
Source DB: PubMed Journal: Tob Induc Dis ISSN: 1617-9625 Impact factor: 2.600
Sociodemographic and smoking characteristics of the study population (N=250)
| 18–65 | 37.2±9.3 | |
| 16.53–41.77 | 25.81±4.15 | |
| 2–105 | 25.74±16.03 | |
| 5–90 | 27.34±11.5 | |
| 0–10 | 6.64±2.22 | |
| 0–32 | 12.36±7.06 | |
| Female | 95 (38.0) | |
| Male | 155 (62.0) | |
| No | 183 (73.2) | |
| Yes | 67 (26.8) | |
| ≤10 | 15 (6.0) | |
| 11–20 | 90 (36.0) | |
| 21–30 | 82 (32.8) | |
| ≥31 | 63 (25.2) | |
| Very low | 13 (5.2) | |
| Low | 30 (12.0) | |
| Moderate | 25 (10.0) | |
| High | 79 (31.6) | |
| Very high | 103 (41.2) | |
BMI: body mass index (kg/m2). FTND: Fagerström test for nicotine dependence. CO: carbon monoxide.
Electrocardiographic findings of the study population (N=250)
| HR (beats/min) | 52–112 | 74.57±10.66 |
| QT max (ms) | 300–440 | 367.19±26.26 |
| QT min (ms) | 275–420 | 343.36±26.93 |
| QTd (ms) | 4–64 | 23.83±13.12 |
| QTc max (ms) | 293–503 | 406.67±26.98 |
| QTc min (ms) | 279–467 | 380.04±26.51 |
| QTcd (ms) | 4–85 | 26.63±15.02 |
HR: heart rate. QT max: QT maximum. QTc max: corrected QT maximum. QT min: QT minimum. QTc min: corrected QT minimum. QTd: QT dispersion. QTcd: corrected QT dispersion.
Relationship between QTd and QTcd and smoking and sociodemographic characteristics (N=250)
| Spearman rho | 0.111 | 0.093 | |
| p | 0.081 | 0.142 | |
| Spearman rho | 0.162 | 0.163 | |
| p | 0.010 | 0.010 | |
| Female | 21.22 (12.12) | 23.67 (13.6) | |
| Male | 25.43 (13.48) | 28.44 (15.6) | |
| p | 0.009 | 0.013 | |
| Spearman rho | 0.328 | 0.312 | |
| p | <0.001 | <0.001 | |
| ≤10 | 10.27±4.38 | 11.67±4.81 | |
| 11–20 | 20.11±11.54 | 22.44±13.4 | |
| 21–30 | 26.34±12.41 | 29.73±14.7 | |
| ≥31 | 29.11±13.89 | 32.13±15.41 | |
| p | <0.001 | <0.001 | |
| Spearman rho | 0.396 | 0.388 | |
| Spearman rho | 0.539 | 0.547 | |
| p | <0.001 | <0.001 | |
| Spearman rho | 0.837 | 0.838 | |
| p | <0.001 | <0.001 | |
| No | 22.89±13.06 | 25.63±15.03 | |
| Yes | 26.4±13.01 | 29.34±14.77 | |
| p | 0.040 | 0.048 |
Data presented as Mean±SD.
Mann-Whitney U test.
Kruskal-Wallis test Pearson correlation analysis.
Spearman rho correlation analysis.
Indicates statistical significance.
BMI: body mass index (kg/m2). CO: carbon monoxide. FTND: Fagerström test for nicotine dependence. QTd: QT dispersion. QTcd: corrected QT dispersion.
Evaluation of the relationship between FTND addiction levels and ECG parameters (N=250)
| Very low (0–2) | 410.15±32.54 | 398.31±35.62 | 10.85±8.23 | 11.85±8.40 |
| Low (3–4) | 395.93±24.27 | 381.07±25.12 | 13.60±6.77 | 14.87±7.22 |
| Moderate (5) | 402.52±34.67 | 378.64±33.47 | 21.68±9.98 | 23.88±11.26 |
| High (6–7) | 405.85±25.58 | 381.62±25.38 | 21.85±10.87 | 24.23±12.13 |
| Very high (8–10) | 410.99±25.35 | 376.56±23.95 | 30.50±13.56 | 34.43±15.78 |
| p | 0.081 | 0.079 | <0.001 | <0.001 |
Data presented as Mean±SD.
p indicates statistical significance.
QTc max: corrected QT maximum. QTc min: corrected QT minimum. QTd: QT dispersion. QTcd: corrected QT dispersion.